AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

✍ Scribed by Gianni, Luca (author);Romieu, Gilles H. (author);Lichinitser, Michail (author);Serrano, Sergio V. (author);Mansutti, Mauro (author);Pivot, Xavier (author);Mariani, Paola (author);Andre, Fabrice (author);Chan, Arlene (author);Lipatov, Oleg (author);Chan, Stephen (author);Wardley, Andrew (author);Greil, Richard (author);Moore, Nicola (author);Prot, Sylvie (author);Pallaud, Celine (author);Semiglazov, Vladimir (author)

• Book ID: 126206876
• Publisher: American Society of Clinical Oncology
• Year: 2013
• Tongue: English
• Weight: 205 KB
• Volume: 31
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2012.44.7912